CD8A and COVID-19: Last, using the spheromer for direct ex vivo study of SARS-CoV-2–specific CD8+ T cells, we show that the T cells predicted to cross-react with seasonal human coronaviruses (hCoV) are significantly enriched in COVID-19 patients with mild symptoms in comparison with individuals with severe disease.